{"entity":{"type":"insider","cik":"0001801917","url":"/insider/0001801917","json_url":"/insider/0001801917.json","name":"Venker Eric","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":91,"n_filings":58,"first":"2022-03-29","last":"2026-07-29","span_basis":"filed_date"},"name_variants":[{"name":"Venker Eric","source":"filing","n_filings":58,"first_seen":"2022-03-29","last_seen":"2026-07-29"}],"transactions":[{"id":6072024,"accession":"0001140361-26-030107","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001140361-26-030107","line_url":"/filing/0001140361-26-030107#line-2","is_derivative":false,"issuer_cik":"0001635088","issuer_name":"Roivant Sciences Ltd.","issuer_ticker":"ROIV","issuer_name_source":null,"issuer_url":"/issuer/0001635088","owner_cik":"0001801917","owner_name":"Venker Eric","owner_display_name":"Venker Eric","owner_url":"/insider/0001801917","role":"Officer (President & Immunovant CEO)","role_mark":"O","role_mark_label":"Officer (President & Immunovant CEO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & Immunovant CEO","security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":200000.0,"shares_display":"200,000","price_per_share":34.95,"price_display":"34.95","price_state":"stated","total_value":6990000.0,"total_display":"6,990,000.00","total_whole":"6,990,000","shares_owned_after":1613063.0,"shares_owned_after_display":"1,613,063","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-07-27","filed_date":"2026-07-29","scope":"insider"},{"id":6115272,"accession":"0001764013-26-000077","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001764013-26-000077","line_url":"/filing/0001764013-26-000077#line-3","is_derivative":false,"issuer_cik":"0001764013","issuer_name":"Immunovant, Inc.","issuer_ticker":"IMVT","issuer_name_source":null,"issuer_url":"/issuer/0001764013","owner_cik":"0001801917","owner_name":"Venker Eric","owner_display_name":"Venker Eric","owner_url":"/insider/0001801917","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3092.0,"shares_display":"3,092","price_per_share":38.48,"price_display":"38.48","price_state":"stated","total_value":118980.16,"total_display":"118,980.16","total_whole":"118,980","shares_owned_after":254280.0,"shares_owned_after_display":"254,280","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-07-02","filed_date":"2026-07-06","scope":"insider"},{"id":5922303,"accession":"0001635088-26-000071","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001635088-26-000071","line_url":"/filing/0001635088-26-000071","is_derivative":false,"issuer_cik":"0001635088","issuer_name":"Roivant Sciences Ltd.","issuer_ticker":"ROIV","issuer_name_source":null,"issuer_url":"/issuer/0001635088","owner_cik":"0001801917","owner_name":"Venker Eric","owner_display_name":"Venker Eric","owner_url":"/insider/0001801917","role":"Officer (President & Immunovant CEO)","role_mark":"O","role_mark_label":"Officer (President & Immunovant CEO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & Immunovant CEO","security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":200000.0,"shares_display":"200,000","price_per_share":33.1563382,"price_display":"33.16","price_state":"stated","total_value":6631267.64,"total_display":"6,631,267.64","total_whole":"6,631,268","shares_owned_after":1659297.0,"shares_owned_after_display":"1,659,297","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-06-24","filed_date":"2026-06-26","scope":"insider","n_lines":2},{"id":5910137,"accession":"0001635088-26-000065","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001635088-26-000065","line_url":"/filing/0001635088-26-000065#line-3","is_derivative":false,"issuer_cik":"0001635088","issuer_name":"Roivant Sciences Ltd.","issuer_ticker":"ROIV","issuer_name_source":null,"issuer_url":"/issuer/0001635088","owner_cik":"0001801917","owner_name":"Venker Eric","owner_display_name":"Venker Eric","owner_url":"/insider/0001801917","role":"Officer (President & Immunovant CEO)","role_mark":"O","role_mark_label":"Officer (President & Immunovant CEO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & Immunovant CEO","security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":200000.0,"shares_display":"200,000","price_per_share":30.27,"price_display":"30.27","price_state":"stated","total_value":6054000.0,"total_display":"6,054,000.00","total_whole":"6,054,000","shares_owned_after":1613063.0,"shares_owned_after_display":"1,613,063","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-05-22","filed_date":"2026-05-22","scope":"insider"},{"id":6113567,"accession":"0001635088-26-000044","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001635088-26-000044","line_url":"/filing/0001635088-26-000044#line-2","is_derivative":false,"issuer_cik":"0001635088","issuer_name":"Roivant Sciences Ltd.","issuer_ticker":"ROIV","issuer_name_source":null,"issuer_url":"/issuer/0001635088","owner_cik":"0001801917","owner_name":"Venker Eric","owner_display_name":"Venker Eric","owner_url":"/insider/0001801917","role":"Officer (President & Immunovant CEO)","role_mark":"O","role_mark_label":"Officer (President & Immunovant CEO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & Immunovant CEO","security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":200000.0,"shares_display":"200,000","price_per_share":29.59,"price_display":"29.59","price_state":"stated","total_value":5918000.0,"total_display":"5,918,000.00","total_whole":"5,918,000","shares_owned_after":1647546.0,"shares_owned_after_display":"1,647,546","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-04-20","filed_date":"2026-04-22","scope":"insider"},{"id":6223202,"accession":"0001764013-26-000024","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001764013-26-000024","line_url":"/filing/0001764013-26-000024","is_derivative":false,"issuer_cik":"0001764013","issuer_name":"Immunovant, Inc.","issuer_ticker":"IMVT","issuer_name_source":null,"issuer_url":"/issuer/0001764013","owner_cik":"0001801917","owner_name":"Venker Eric","owner_display_name":"Venker Eric","owner_url":"/insider/0001801917","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":14229.0,"shares_display":"14,229","price_per_share":24.095452948204372,"price_display":"24.10","price_state":"stated","total_value":342854.2,"total_display":"342,854.20","total_whole":"342,854","shares_owned_after":20970.0,"shares_owned_after_display":"20,970","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-04-02","filed_date":"2026-04-03","scope":"insider","n_lines":2},{"id":5757707,"accession":"0001635088-26-000026","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001635088-26-000026","line_url":"/filing/0001635088-26-000026#line-2","is_derivative":false,"issuer_cik":"0001635088","issuer_name":"Roivant Sciences Ltd.","issuer_ticker":"ROIV","issuer_name_source":null,"issuer_url":"/issuer/0001635088","owner_cik":"0001801917","owner_name":"Venker Eric","owner_display_name":"Venker Eric","owner_url":"/insider/0001801917","role":"Officer (President & Immunovant CEO)","role_mark":"O","role_mark_label":"Officer (President & Immunovant CEO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & Immunovant CEO","security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":200000.0,"shares_display":"200,000","price_per_share":28.24,"price_display":"28.24","price_state":"stated","total_value":5648000.0,"total_display":"5,648,000.00","total_whole":"5,648,000","shares_owned_after":1647546.0,"shares_owned_after_display":"1,647,546","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-03-17","filed_date":"2026-03-19","scope":"insider"},{"id":5766988,"accession":"0001635088-26-000017","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001635088-26-000017","line_url":"/filing/0001635088-26-000017#line-2","is_derivative":false,"issuer_cik":"0001635088","issuer_name":"Roivant Sciences Ltd.","issuer_ticker":"ROIV","issuer_name_source":null,"issuer_url":"/issuer/0001635088","owner_cik":"0001801917","owner_name":"Venker Eric","owner_display_name":"Venker Eric","owner_url":"/insider/0001801917","role":"Officer (President & Immunovant CEO)","role_mark":"O","role_mark_label":"Officer (President & Immunovant CEO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & Immunovant CEO","security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":200000.0,"shares_display":"200,000","price_per_share":26.49,"price_display":"26.49","price_state":"stated","total_value":5298000.0,"total_display":"5,298,000.00","total_whole":"5,298,000","shares_owned_after":1654597.0,"shares_owned_after_display":"1,654,597","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-02-13","filed_date":"2026-02-18","scope":"insider"},{"id":5928927,"accession":"0001140361-26-001239","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001140361-26-001239","line_url":"/filing/0001140361-26-001239#line-2","is_derivative":false,"issuer_cik":"0001635088","issuer_name":"Roivant Sciences Ltd.","issuer_ticker":"ROIV","issuer_name_source":null,"issuer_url":"/issuer/0001635088","owner_cik":"0001801917","owner_name":"Venker Eric","owner_display_name":"Venker Eric","owner_url":"/insider/0001801917","role":"Officer (President & Immunovant CEO)","role_mark":"O","role_mark_label":"Officer (President & Immunovant CEO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & Immunovant CEO","security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":200000.0,"shares_display":"200,000","price_per_share":21.92,"price_display":"21.92","price_state":"stated","total_value":4384000.0,"total_display":"4,384,000.00","total_whole":"4,384,000","shares_owned_after":1654597.0,"shares_owned_after_display":"1,654,597","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-01-12","filed_date":"2026-01-14","scope":"insider"},{"id":4342952,"accession":"0001140361-25-046786","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001140361-25-046786","line_url":"/filing/0001140361-25-046786#line-4","is_derivative":false,"issuer_cik":"0001635088","issuer_name":"Roivant Sciences Ltd.","issuer_ticker":"ROIV","issuer_name_source":null,"issuer_url":"/issuer/0001635088","owner_cik":"0001801917","owner_name":"Venker Eric","owner_display_name":"Venker Eric","owner_url":"/insider/0001801917","role":"Officer (President & Immunovant CEO)","role_mark":"O","role_mark_label":"Officer (President & Immunovant CEO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & Immunovant CEO","security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":75000.0,"shares_display":"75,000","price_per_share":22.53,"price_display":"22.53","price_state":"stated","total_value":1689750.0,"total_display":"1,689,750.00","total_whole":"1,689,750","shares_owned_after":1654597.0,"shares_owned_after_display":"1,654,597","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-12-24","filed_date":"2025-12-29","scope":"insider"},{"id":4342946,"accession":"0001140361-25-046786","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001140361-25-046786","line_url":"/filing/0001140361-25-046786#line-2","is_derivative":false,"issuer_cik":"0001635088","issuer_name":"Roivant Sciences Ltd.","issuer_ticker":"ROIV","issuer_name_source":null,"issuer_url":"/issuer/0001635088","owner_cik":"0001801917","owner_name":"Venker Eric","owner_display_name":"Venker Eric","owner_url":"/insider/0001801917","role":"Officer (President & Immunovant CEO)","role_mark":"O","role_mark_label":"Officer (President & Immunovant CEO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & Immunovant CEO","security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":200000.0,"shares_display":"200,000","price_per_share":22.45,"price_display":"22.45","price_state":"stated","total_value":4490000.0,"total_display":"4,490,000.00","total_whole":"4,490,000","shares_owned_after":1611749.0,"shares_owned_after_display":"1,611,749","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-12-23","filed_date":"2025-12-29","scope":"insider"},{"id":4622203,"accession":"0001140361-25-045279","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001140361-25-045279","line_url":"/filing/0001140361-25-045279#line-2","is_derivative":false,"issuer_cik":"0001635088","issuer_name":"Roivant Sciences Ltd.","issuer_ticker":"ROIV","issuer_name_source":null,"issuer_url":"/issuer/0001635088","owner_cik":"0001801917","owner_name":"Venker Eric","owner_display_name":"Venker Eric","owner_url":"/insider/0001801917","role":"Officer (President & Immunovant CEO)","role_mark":"O","role_mark_label":"Officer (President & Immunovant CEO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & Immunovant CEO","security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":200000.0,"shares_display":"200,000","price_per_share":20.85,"price_display":"20.85","price_state":"stated","total_value":4170000.0,"total_display":"4,170,000.00","total_whole":"4,170,000","shares_owned_after":1497908.0,"shares_owned_after_display":"1,497,908","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-12-09","filed_date":"2025-12-11","scope":"insider"},{"id":4371530,"accession":"0001140361-25-041214","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001140361-25-041214","line_url":"/filing/0001140361-25-041214#line-2","is_derivative":false,"issuer_cik":"0001635088","issuer_name":"Roivant Sciences Ltd.","issuer_ticker":"ROIV","issuer_name_source":null,"issuer_url":"/issuer/0001635088","owner_cik":"0001801917","owner_name":"Venker Eric","owner_display_name":"Venker Eric","owner_url":"/insider/0001801917","role":"Officer (President & Immunovant CEO)","role_mark":"O","role_mark_label":"Officer (President & Immunovant CEO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & Immunovant CEO","security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":200000.0,"shares_display":"200,000","price_per_share":20.22,"price_display":"20.22","price_state":"stated","total_value":4044000.0,"total_display":"4,044,000.00","total_whole":"4,044,000","shares_owned_after":1504959.0,"shares_owned_after_display":"1,504,959","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-11-07","filed_date":"2025-11-07","scope":"insider"},{"id":4044254,"accession":"0001140361-25-038545","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001140361-25-038545","line_url":"/filing/0001140361-25-038545#line-6","is_derivative":false,"issuer_cik":"0001635088","issuer_name":"Roivant Sciences Ltd.","issuer_ticker":"ROIV","issuer_name_source":null,"issuer_url":"/issuer/0001635088","owner_cik":"0001801917","owner_name":"Venker Eric","owner_display_name":"Venker Eric","owner_url":"/insider/0001801917","role":"Officer (President & Immunovant CEO)","role_mark":"O","role_mark_label":"Officer (President & Immunovant CEO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & Immunovant CEO","security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":118418.0,"shares_display":"118,418","price_per_share":17.06,"price_display":"17.06","price_state":"stated","total_value":2020211.08,"total_display":"2,020,211.08","total_whole":"2,020,211","shares_owned_after":1504959.0,"shares_owned_after_display":"1,504,959","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-10-17","filed_date":"2025-10-17","scope":"insider"},{"id":4044251,"accession":"0001140361-25-038545","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001140361-25-038545","line_url":"/filing/0001140361-25-038545#line-4","is_derivative":false,"issuer_cik":"0001635088","issuer_name":"Roivant Sciences Ltd.","issuer_ticker":"ROIV","issuer_name_source":null,"issuer_url":"/issuer/0001635088","owner_cik":"0001801917","owner_name":"Venker Eric","owner_display_name":"Venker Eric","owner_url":"/insider/0001801917","role":"Officer (President & Immunovant CEO)","role_mark":"O","role_mark_label":"Officer (President & Immunovant CEO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & Immunovant CEO","security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":318282.0,"shares_display":"318,282","price_per_share":17.05,"price_display":"17.05","price_state":"stated","total_value":5426708.1,"total_display":"5,426,708.10","total_whole":"5,426,708","shares_owned_after":1504959.0,"shares_owned_after_display":"1,504,959","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-10-16","filed_date":"2025-10-17","scope":"insider"},{"id":4044247,"accession":"0001140361-25-038545","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001140361-25-038545","line_url":"/filing/0001140361-25-038545#line-2","is_derivative":false,"issuer_cik":"0001635088","issuer_name":"Roivant Sciences Ltd.","issuer_ticker":"ROIV","issuer_name_source":null,"issuer_url":"/issuer/0001635088","owner_cik":"0001801917","owner_name":"Venker Eric","owner_display_name":"Venker Eric","owner_url":"/insider/0001801917","role":"Officer (President & Immunovant CEO)","role_mark":"O","role_mark_label":"Officer (President & Immunovant CEO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & Immunovant CEO","security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":414683.0,"shares_display":"414,683","price_per_share":16.93,"price_display":"16.93","price_state":"stated","total_value":7020583.19,"total_display":"7,020,583.19","total_whole":"7,020,583","shares_owned_after":1504959.0,"shares_owned_after_display":"1,504,959","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-10-15","filed_date":"2025-10-17","scope":"insider"},{"id":4134687,"accession":"0001140361-25-038126","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001140361-25-038126","line_url":"/filing/0001140361-25-038126#line-4","is_derivative":false,"issuer_cik":"0001635088","issuer_name":"Roivant Sciences Ltd.","issuer_ticker":"ROIV","issuer_name_source":null,"issuer_url":"/issuer/0001635088","owner_cik":"0001801917","owner_name":"Venker Eric","owner_display_name":"Venker Eric","owner_url":"/insider/0001801917","role":"Officer (President & Immunovant CEO)","role_mark":"O","role_mark_label":"Officer (President & Immunovant CEO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & Immunovant CEO","security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":20727.0,"shares_display":"20,727","price_per_share":16.25,"price_display":"16.25","price_state":"stated","total_value":336813.75,"total_display":"336,813.75","total_whole":"336,814","shares_owned_after":1504959.0,"shares_owned_after_display":"1,504,959","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-10-13","filed_date":"2025-10-14","scope":"insider"},{"id":4134681,"accession":"0001140361-25-038126","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001140361-25-038126","line_url":"/filing/0001140361-25-038126#line-2","is_derivative":false,"issuer_cik":"0001635088","issuer_name":"Roivant Sciences Ltd.","issuer_ticker":"ROIV","issuer_name_source":null,"issuer_url":"/issuer/0001635088","owner_cik":"0001801917","owner_name":"Venker Eric","owner_display_name":"Venker Eric","owner_url":"/insider/0001801917","role":"Officer (President & Immunovant CEO)","role_mark":"O","role_mark_label":"Officer (President & Immunovant CEO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & Immunovant CEO","security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":104940.0,"shares_display":"104,940","price_per_share":16.3,"price_display":"16.30","price_state":"stated","total_value":1710522.0,"total_display":"1,710,522.00","total_whole":"1,710,522","shares_owned_after":1504959.0,"shares_owned_after_display":"1,504,959","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-10-09","filed_date":"2025-10-14","scope":"insider"},{"id":4229036,"accession":"0001140361-25-037740","txn_seq":11,"anchor":"line-11","filing_url":"/filing/0001140361-25-037740","line_url":"/filing/0001140361-25-037740#line-11","is_derivative":false,"issuer_cik":"0001635088","issuer_name":"Roivant Sciences Ltd.","issuer_ticker":"ROIV","issuer_name_source":null,"issuer_url":"/issuer/0001635088","owner_cik":"0001801917","owner_name":"Venker Eric","owner_display_name":"Venker Eric","owner_url":"/insider/0001801917","role":"Officer (President & Immunovant CEO)","role_mark":"O","role_mark_label":"Officer (President & Immunovant CEO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & Immunovant CEO","security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":138602.0,"shares_display":"138,602","price_per_share":16.2,"price_display":"16.20","price_state":"stated","total_value":2245352.4,"total_display":"2,245,352.40","total_whole":"2,245,352","shares_owned_after":1504959.0,"shares_owned_after_display":"1,504,959","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-10-08","filed_date":"2025-10-08","scope":"insider"},{"id":4229024,"accession":"0001140361-25-037740","txn_seq":8,"anchor":"line-8","filing_url":"/filing/0001140361-25-037740","line_url":"/filing/0001140361-25-037740#line-8","is_derivative":false,"issuer_cik":"0001635088","issuer_name":"Roivant Sciences Ltd.","issuer_ticker":"ROIV","issuer_name_source":null,"issuer_url":"/issuer/0001635088","owner_cik":"0001801917","owner_name":"Venker Eric","owner_display_name":"Venker Eric","owner_url":"/insider/0001801917","role":"Officer (President & Immunovant CEO)","role_mark":"O","role_mark_label":"Officer (President & Immunovant CEO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & Immunovant CEO","security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":355161.0,"shares_display":"355,161","price_per_share":16.15,"price_display":"16.15","price_state":"stated","total_value":5735850.15,"total_display":"5,735,850.15","total_whole":"5,735,850","shares_owned_after":1504959.0,"shares_owned_after_display":"1,504,959","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-10-07","filed_date":"2025-10-08","scope":"insider"},{"id":4229002,"accession":"0001140361-25-037740","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001140361-25-037740","line_url":"/filing/0001140361-25-037740#line-4","is_derivative":false,"issuer_cik":"0001635088","issuer_name":"Roivant Sciences Ltd.","issuer_ticker":"ROIV","issuer_name_source":null,"issuer_url":"/issuer/0001635088","owner_cik":"0001801917","owner_name":"Venker Eric","owner_display_name":"Venker Eric","owner_url":"/insider/0001801917","role":"Officer (President & Immunovant CEO)","role_mark":"O","role_mark_label":"Officer (President & Immunovant CEO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & Immunovant CEO","security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":171396.0,"shares_display":"171,396","price_per_share":16.34,"price_display":"16.34","price_state":"stated","total_value":2800610.64,"total_display":"2,800,610.64","total_whole":"2,800,611","shares_owned_after":1504959.0,"shares_owned_after_display":"1,504,959","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-10-06","filed_date":"2025-10-08","scope":"insider"},{"id":4371511,"accession":"0001140361-25-035890","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0001140361-25-035890","line_url":"/filing/0001140361-25-035890#line-7","is_derivative":false,"issuer_cik":"0001635088","issuer_name":"Roivant Sciences Ltd.","issuer_ticker":"ROIV","issuer_name_source":null,"issuer_url":"/issuer/0001635088","owner_cik":"0001801917","owner_name":"Venker Eric","owner_display_name":"Venker Eric","owner_url":"/insider/0001801917","role":"Officer (President & Immunovant CEO)","role_mark":"O","role_mark_label":"Officer (President & Immunovant CEO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & Immunovant CEO","security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":611000.0,"shares_display":"611,000","price_per_share":14.83,"price_display":"14.83","price_state":"stated","total_value":9061130.0,"total_display":"9,061,130.00","total_whole":"9,061,130","shares_owned_after":1504959.0,"shares_owned_after_display":"1,504,959","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-09-23","filed_date":"2025-09-23","scope":"insider"},{"id":4371509,"accession":"0001140361-25-035890","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001140361-25-035890","line_url":"/filing/0001140361-25-035890","is_derivative":false,"issuer_cik":"0001635088","issuer_name":"Roivant Sciences Ltd.","issuer_ticker":"ROIV","issuer_name_source":null,"issuer_url":"/issuer/0001635088","owner_cik":"0001801917","owner_name":"Venker Eric","owner_display_name":"Venker Eric","owner_url":"/insider/0001801917","role":"Officer (President & Immunovant CEO)","role_mark":"O","role_mark_label":"Officer (President & Immunovant CEO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & Immunovant CEO","security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":416182.0,"shares_display":"416,182","price_per_share":14.994805589862128,"price_display":"14.99","price_state":"stated","total_value":6240568.18,"total_display":"6,240,568.18","total_whole":"6,240,568","shares_owned_after":2215959.0,"shares_owned_after_display":"2,215,959","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-09-22","filed_date":"2025-09-23","scope":"insider","n_lines":2},{"id":4371499,"accession":"0001140361-25-035890","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001140361-25-035890","line_url":"/filing/0001140361-25-035890#line-2","is_derivative":false,"issuer_cik":"0001635088","issuer_name":"Roivant Sciences Ltd.","issuer_ticker":"ROIV","issuer_name_source":null,"issuer_url":"/issuer/0001635088","owner_cik":"0001801917","owner_name":"Venker Eric","owner_display_name":"Venker Eric","owner_url":"/insider/0001801917","role":"Officer (President & Immunovant CEO)","role_mark":"O","role_mark_label":"Officer (President & Immunovant CEO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & Immunovant CEO","security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":683818.0,"shares_display":"683,818","price_per_share":14.95,"price_display":"14.95","price_state":"stated","total_value":10223079.1,"total_display":"10,223,079.10","total_whole":"10,223,079","shares_owned_after":1969767.0,"shares_owned_after_display":"1,969,767","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-09-19","filed_date":"2025-09-23","scope":"insider"},{"id":4228936,"accession":"0001140361-25-032404","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001140361-25-032404","line_url":"/filing/0001140361-25-032404#line-3","is_derivative":false,"issuer_cik":"0001635088","issuer_name":"Roivant Sciences Ltd.","issuer_ticker":"ROIV","issuer_name_source":null,"issuer_url":"/issuer/0001635088","owner_cik":"0001801917","owner_name":"Venker Eric","owner_display_name":"Venker Eric","owner_url":"/insider/0001801917","role":"Officer (President & Immunovant CEO)","role_mark":"O","role_mark_label":"Officer (President & Immunovant CEO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & Immunovant CEO","security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":100000.0,"shares_display":"100,000","price_per_share":11.72,"price_display":"11.72","price_state":"stated","total_value":1172000.0,"total_display":"1,172,000.00","total_whole":"1,172,000","shares_owned_after":1653585.0,"shares_owned_after_display":"1,653,585","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-08-20","filed_date":"2025-08-22","scope":"insider"},{"id":4201276,"accession":"0001140361-25-027005","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001140361-25-027005","line_url":"/filing/0001140361-25-027005#line-2","is_derivative":false,"issuer_cik":"0001635088","issuer_name":"Roivant Sciences Ltd.","issuer_ticker":"ROIV","issuer_name_source":null,"issuer_url":"/issuer/0001635088","owner_cik":"0001801917","owner_name":"Venker Eric","owner_display_name":"Venker Eric","owner_url":"/insider/0001801917","role":"Officer (President & Immunovant CEO)","role_mark":"O","role_mark_label":"Officer (President & Immunovant CEO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & Immunovant CEO","security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":100000.0,"shares_display":"100,000","price_per_share":11.52,"price_display":"11.52","price_state":"stated","total_value":1152000.0,"total_display":"1,152,000.00","total_whole":"1,152,000","shares_owned_after":1462223.0,"shares_owned_after_display":"1,462,223","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-07-21","filed_date":"2025-07-23","scope":"insider"},{"id":4425144,"accession":"0001140361-25-023521","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001140361-25-023521","line_url":"/filing/0001140361-25-023521#line-2","is_derivative":false,"issuer_cik":"0001635088","issuer_name":"Roivant Sciences Ltd.","issuer_ticker":"ROIV","issuer_name_source":null,"issuer_url":"/issuer/0001635088","owner_cik":"0001801917","owner_name":"Venker Eric","owner_display_name":"Venker Eric","owner_url":"/insider/0001801917","role":"Officer (President & COO)","role_mark":"O","role_mark_label":"Officer (President & COO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & COO","security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":100000.0,"shares_display":"100,000","price_per_share":11.45,"price_display":"11.45","price_state":"stated","total_value":1145000.0,"total_display":"1,145,000.00","total_whole":"1,145,000","shares_owned_after":1462223.0,"shares_owned_after_display":"1,462,223","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-06-20","filed_date":"2025-06-24","scope":"insider"},{"id":4092299,"accession":"0001140361-25-021455","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001140361-25-021455","line_url":"/filing/0001140361-25-021455#line-4","is_derivative":false,"issuer_cik":"0001635088","issuer_name":"Roivant Sciences Ltd.","issuer_ticker":"ROIV","issuer_name_source":null,"issuer_url":"/issuer/0001635088","owner_cik":"0001801917","owner_name":"Venker Eric","owner_display_name":"Venker Eric","owner_url":"/insider/0001801917","role":"Officer (President & COO)","role_mark":"O","role_mark_label":"Officer (President & COO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & COO","security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":566278.0,"shares_display":"566,278","price_per_share":11.22,"price_display":"11.22","price_state":"stated","total_value":6353639.16,"total_display":"6,353,639.16","total_whole":"6,353,639","shares_owned_after":1462223.0,"shares_owned_after_display":"1,462,223","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-06-03","filed_date":"2025-06-04","scope":"insider"},{"id":4092293,"accession":"0001140361-25-021455","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001140361-25-021455","line_url":"/filing/0001140361-25-021455#line-2","is_derivative":false,"issuer_cik":"0001635088","issuer_name":"Roivant Sciences Ltd.","issuer_ticker":"ROIV","issuer_name_source":null,"issuer_url":"/issuer/0001635088","owner_cik":"0001801917","owner_name":"Venker Eric","owner_display_name":"Venker Eric","owner_url":"/insider/0001801917","role":"Officer (President & COO)","role_mark":"O","role_mark_label":"Officer (President & COO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & COO","security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":433722.0,"shares_display":"433,722","price_per_share":11.07,"price_display":"11.07","price_state":"stated","total_value":4801302.54,"total_display":"4,801,302.54","total_whole":"4,801,303","shares_owned_after":1243475.0,"shares_owned_after_display":"1,243,475","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-06-02","filed_date":"2025-06-04","scope":"insider"},{"id":4044146,"accession":"0001140361-25-020241","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001140361-25-020241","line_url":"/filing/0001140361-25-020241#line-3","is_derivative":false,"issuer_cik":"0001635088","issuer_name":"Roivant Sciences Ltd.","issuer_ticker":"ROIV","issuer_name_source":null,"issuer_url":"/issuer/0001635088","owner_cik":"0001801917","owner_name":"Venker Eric","owner_display_name":"Venker Eric","owner_url":"/insider/0001801917","role":"Officer (President & COO)","role_mark":"O","role_mark_label":"Officer (President & COO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & COO","security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":100000.0,"shares_display":"100,000","price_per_share":10.95,"price_display":"10.95","price_state":"stated","total_value":1095000.0,"total_display":"1,095,000.00","total_whole":"1,095,000","shares_owned_after":1077197.0,"shares_owned_after_display":"1,077,197","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-05-20","filed_date":"2025-05-22","scope":"insider"},{"id":5107092,"accession":"0001140361-25-014986","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001140361-25-014986","line_url":"/filing/0001140361-25-014986#line-3","is_derivative":false,"issuer_cik":"0001635088","issuer_name":"Roivant Sciences Ltd.","issuer_ticker":"ROIV","issuer_name_source":null,"issuer_url":"/issuer/0001635088","owner_cik":"0001801917","owner_name":"Venker Eric","owner_display_name":"Venker Eric","owner_url":"/insider/0001801917","role":"Officer (President & COO)","role_mark":"O","role_mark_label":"Officer (President & COO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & COO","security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":100000.0,"shares_display":"100,000","price_per_share":10.22,"price_display":"10.22","price_state":"stated","total_value":1022000.0,"total_display":"1,022,000.00","total_whole":"1,022,000","shares_owned_after":1116345.0,"shares_owned_after_display":"1,116,345","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-04-21","filed_date":"2025-04-22","scope":"insider"},{"id":4795006,"accession":"0001140361-25-010120","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001140361-25-010120","line_url":"/filing/0001140361-25-010120#line-5","is_derivative":false,"issuer_cik":"0001635088","issuer_name":"Roivant Sciences Ltd.","issuer_ticker":"ROIV","issuer_name_source":null,"issuer_url":"/issuer/0001635088","owner_cik":"0001801917","owner_name":"Venker Eric","owner_display_name":"Venker Eric","owner_url":"/insider/0001801917","role":"Officer (President & COO)","role_mark":"O","role_mark_label":"Officer (President & COO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & COO","security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":434478.0,"shares_display":"434,478","price_per_share":10.82,"price_display":"10.82","price_state":"stated","total_value":4701051.96,"total_display":"4,701,051.96","total_whole":"4,701,052","shares_owned_after":1127290.0,"shares_owned_after_display":"1,127,290","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-03-24","filed_date":"2025-03-24","scope":"insider"},{"id":4794998,"accession":"0001140361-25-010120","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001140361-25-010120","line_url":"/filing/0001140361-25-010120#line-3","is_derivative":false,"issuer_cik":"0001635088","issuer_name":"Roivant Sciences Ltd.","issuer_ticker":"ROIV","issuer_name_source":null,"issuer_url":"/issuer/0001635088","owner_cik":"0001801917","owner_name":"Venker Eric","owner_display_name":"Venker Eric","owner_url":"/insider/0001801917","role":"Officer (President & COO)","role_mark":"O","role_mark_label":"Officer (President & COO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & COO","security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":315522.0,"shares_display":"315,522","price_per_share":11.06,"price_display":"11.06","price_state":"stated","total_value":3489673.32,"total_display":"3,489,673.32","total_whole":"3,489,673","shares_owned_after":959457.0,"shares_owned_after_display":"959,457","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-03-20","filed_date":"2025-03-24","scope":"insider"},{"id":4844163,"accession":"0001140361-25-005717","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001140361-25-005717","line_url":"/filing/0001140361-25-005717#line-3","is_derivative":false,"issuer_cik":"0001635088","issuer_name":"Roivant Sciences Ltd.","issuer_ticker":"ROIV","issuer_name_source":null,"issuer_url":"/issuer/0001635088","owner_cik":"0001801917","owner_name":"Venker Eric","owner_display_name":"Venker Eric","owner_url":"/insider/0001801917","role":"Officer (President & COO)","role_mark":"O","role_mark_label":"Officer (President & COO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & COO","security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":100000.0,"shares_display":"100,000","price_per_share":10.65,"price_display":"10.65","price_state":"stated","total_value":1065000.0,"total_display":"1,065,000.00","total_whole":"1,065,000","shares_owned_after":896869.0,"shares_owned_after_display":"896,869","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-02-20","filed_date":"2025-02-24","scope":"insider"},{"id":4671348,"accession":"0001140361-25-004951","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001140361-25-004951","line_url":"/filing/0001140361-25-004951#line-4","is_derivative":false,"issuer_cik":"0001635088","issuer_name":"Roivant Sciences Ltd.","issuer_ticker":"ROIV","issuer_name_source":null,"issuer_url":"/issuer/0001635088","owner_cik":"0001801917","owner_name":"Venker Eric","owner_display_name":"Venker Eric","owner_url":"/insider/0001801917","role":"Officer (President & COO)","role_mark":"O","role_mark_label":"Officer (President & COO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & COO","security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":218041.0,"shares_display":"218,041","price_per_share":10.42,"price_display":"10.42","price_state":"stated","total_value":2271987.22,"total_display":"2,271,987.22","total_whole":"2,271,987","shares_owned_after":896869.0,"shares_owned_after_display":"896,869","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-02-13","filed_date":"2025-02-14","scope":"insider"},{"id":4671330,"accession":"0001140361-25-004951","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001140361-25-004951","line_url":"/filing/0001140361-25-004951#line-2","is_derivative":false,"issuer_cik":"0001635088","issuer_name":"Roivant Sciences Ltd.","issuer_ticker":"ROIV","issuer_name_source":null,"issuer_url":"/issuer/0001635088","owner_cik":"0001801917","owner_name":"Venker Eric","owner_display_name":"Venker Eric","owner_url":"/insider/0001801917","role":"Officer (President & COO)","role_mark":"O","role_mark_label":"Officer (President & COO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & COO","security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":217384.0,"shares_display":"217,384","price_per_share":10.53,"price_display":"10.53","price_state":"stated","total_value":2289053.52,"total_display":"2,289,053.52","total_whole":"2,289,054","shares_owned_after":732294.0,"shares_owned_after_display":"732,294","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-02-12","filed_date":"2025-02-14","scope":"insider"},{"id":4201139,"accession":"0001140361-25-001662","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001140361-25-001662","line_url":"/filing/0001140361-25-001662#line-3","is_derivative":false,"issuer_cik":"0001635088","issuer_name":"Roivant Sciences Ltd.","issuer_ticker":"ROIV","issuer_name_source":null,"issuer_url":"/issuer/0001635088","owner_cik":"0001801917","owner_name":"Venker Eric","owner_display_name":"Venker Eric","owner_url":"/insider/0001801917","role":"Officer (President & COO)","role_mark":"O","role_mark_label":"Officer (President & COO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & COO","security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":100000.0,"shares_display":"100,000","price_per_share":11.28,"price_display":"11.28","price_state":"stated","total_value":1128000.0,"total_display":"1,128,000.00","total_whole":"1,128,000","shares_owned_after":732294.0,"shares_owned_after_display":"732,294","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-01-21","filed_date":"2025-01-22","scope":"insider"},{"id":2059674,"accession":"0001140361-24-050723","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001140361-24-050723","line_url":"/filing/0001140361-24-050723#line-4","is_derivative":false,"issuer_cik":"0001635088","issuer_name":"Roivant Sciences Ltd.","issuer_ticker":"ROIV","issuer_name_source":null,"issuer_url":"/issuer/0001635088","owner_cik":"0001801917","owner_name":"Venker Eric","owner_display_name":"Venker Eric","owner_url":"/insider/0001801917","role":"Officer (President & COO)","role_mark":"O","role_mark_label":"Officer (President & COO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & COO","security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":177704.0,"shares_display":"177,704","price_per_share":11.54,"price_display":"11.54","price_state":"stated","total_value":2050704.16,"total_display":"2,050,704.16","total_whole":"2,050,704","shares_owned_after":740976.0,"shares_owned_after_display":"740,976","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-12-30","filed_date":"2024-12-31","scope":"insider"},{"id":2059672,"accession":"0001140361-24-050723","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001140361-24-050723","line_url":"/filing/0001140361-24-050723#line-2","is_derivative":false,"issuer_cik":"0001635088","issuer_name":"Roivant Sciences Ltd.","issuer_ticker":"ROIV","issuer_name_source":null,"issuer_url":"/issuer/0001635088","owner_cik":"0001801917","owner_name":"Venker Eric","owner_display_name":"Venker Eric","owner_url":"/insider/0001801917","role":"Officer (President & COO)","role_mark":"O","role_mark_label":"Officer (President & COO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & COO","security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":176900.0,"shares_display":"176,900","price_per_share":11.82,"price_display":"11.82","price_state":"stated","total_value":2090958.0,"total_display":"2,090,958.00","total_whole":"2,090,958","shares_owned_after":668680.0,"shares_owned_after_display":"668,680","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-12-27","filed_date":"2024-12-31","scope":"insider"},{"id":2247515,"accession":"0001140361-24-050458","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001140361-24-050458","line_url":"/filing/0001140361-24-050458#line-3","is_derivative":false,"issuer_cik":"0001635088","issuer_name":"Roivant Sciences Ltd.","issuer_ticker":"ROIV","issuer_name_source":null,"issuer_url":"/issuer/0001635088","owner_cik":"0001801917","owner_name":"Venker Eric","owner_display_name":"Venker Eric","owner_url":"/insider/0001801917","role":"Officer (President & COO)","role_mark":"O","role_mark_label":"Officer (President & COO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & COO","security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":100000.0,"shares_display":"100,000","price_per_share":11.49,"price_display":"11.49","price_state":"stated","total_value":1149000.0,"total_display":"1,149,000.00","total_whole":"1,149,000","shares_owned_after":595580.0,"shares_owned_after_display":"595,580","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-12-20","filed_date":"2024-12-26","scope":"insider"},{"id":2466840,"accession":"0001140361-24-047697","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001140361-24-047697","line_url":"/filing/0001140361-24-047697#line-3","is_derivative":false,"issuer_cik":"0001635088","issuer_name":"Roivant Sciences Ltd.","issuer_ticker":"ROIV","issuer_name_source":null,"issuer_url":"/issuer/0001635088","owner_cik":"0001801917","owner_name":"Venker Eric","owner_display_name":"Venker Eric","owner_url":"/insider/0001801917","role":"Officer (President & COO)","role_mark":"O","role_mark_label":"Officer (President & COO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & COO","security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":100000.0,"shares_display":"100,000","price_per_share":11.32,"price_display":"11.32","price_state":"stated","total_value":1132000.0,"total_display":"1,132,000.00","total_whole":"1,132,000","shares_owned_after":606525.0,"shares_owned_after_display":"606,525","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-11-20","filed_date":"2024-11-22","scope":"insider"},{"id":2174277,"accession":"0001140361-24-043962","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001140361-24-043962","line_url":"/filing/0001140361-24-043962#line-3","is_derivative":false,"issuer_cik":"0001635088","issuer_name":"Roivant Sciences Ltd.","issuer_ticker":"ROIV","issuer_name_source":null,"issuer_url":"/issuer/0001635088","owner_cik":"0001801917","owner_name":"Venker Eric","owner_display_name":"Venker Eric","owner_url":"/insider/0001801917","role":"Officer (President & COO)","role_mark":"O","role_mark_label":"Officer (President & COO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & COO","security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":100000.0,"shares_display":"100,000","price_per_share":11.65,"price_display":"11.65","price_state":"stated","total_value":1165000.0,"total_display":"1,165,000.00","total_whole":"1,165,000","shares_owned_after":617470.0,"shares_owned_after_display":"617,470","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-10-21","filed_date":"2024-10-22","scope":"insider"},{"id":2088596,"accession":"0001140361-24-006833","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001140361-24-006833","line_url":"/filing/0001140361-24-006833#line-2","is_derivative":false,"issuer_cik":"0001635088","issuer_name":"Roivant Sciences Ltd.","issuer_ticker":"ROIV","issuer_name_source":null,"issuer_url":"/issuer/0001635088","owner_cik":"0001801917","owner_name":"Venker Eric","owner_display_name":"Venker Eric","owner_url":"/insider/0001801917","role":"Officer (President & COO)","role_mark":"O","role_mark_label":"Officer (President & COO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & COO","security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":96950.0,"shares_display":"96,950","price_per_share":10.92,"price_display":"10.92","price_state":"stated","total_value":1058694.0,"total_display":"1,058,694.00","total_whole":"1,058,694","shares_owned_after":532207.0,"shares_owned_after_display":"532,207","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-02-09","filed_date":"2024-02-09","scope":"insider"},{"id":8650510,"accession":"0001140361-23-047044","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001140361-23-047044","line_url":"/filing/0001140361-23-047044#line-4","is_derivative":false,"issuer_cik":"0001635088","issuer_name":"Roivant Sciences Ltd.","issuer_ticker":"ROIV","issuer_name_source":null,"issuer_url":"/issuer/0001635088","owner_cik":"0001801917","owner_name":"Venker Eric","owner_display_name":"Venker Eric","owner_url":"/insider/0001801917","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":606221.0,"shares_display":"606,221","price_per_share":10.25,"price_display":"10.25","price_state":"stated","total_value":6213765.25,"total_display":"6,213,765.25","total_whole":"6,213,765","shares_owned_after":595397.0,"shares_owned_after_display":"595,397","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-10-03","filed_date":"2023-10-04","scope":"insider"},{"id":8650507,"accession":"0001140361-23-047044","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001140361-23-047044","line_url":"/filing/0001140361-23-047044#line-2","is_derivative":false,"issuer_cik":"0001635088","issuer_name":"Roivant Sciences Ltd.","issuer_ticker":"ROIV","issuer_name_source":null,"issuer_url":"/issuer/0001635088","owner_cik":"0001801917","owner_name":"Venker Eric","owner_display_name":"Venker Eric","owner_url":"/insider/0001801917","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":440752.0,"shares_display":"440,752","price_per_share":10.8,"price_display":"10.80","price_state":"stated","total_value":4760121.6,"total_display":"4,760,121.60","total_whole":"4,760,122","shares_owned_after":595397.0,"shares_owned_after_display":"595,397","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-10-02","filed_date":"2023-10-04","scope":"insider"},{"id":7828402,"accession":"0001140361-23-046110","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001140361-23-046110","line_url":"/filing/0001140361-23-046110#line-2","is_derivative":false,"issuer_cik":"0001635088","issuer_name":"Roivant Sciences Ltd.","issuer_ticker":"ROIV","issuer_name_source":null,"issuer_url":"/issuer/0001635088","owner_cik":"0001801917","owner_name":"Venker Eric","owner_display_name":"Venker Eric","owner_url":"/insider/0001801917","role":"Officer (President & COO)","role_mark":"O","role_mark_label":"Officer (President & COO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & COO","security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":500000.0,"shares_display":"500,000","price_per_share":13.02,"price_display":"13.02","price_state":"stated","total_value":6510000.0,"total_display":"6,510,000.00","total_whole":"6,510,000","shares_owned_after":595397.0,"shares_owned_after_display":"595,397","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-09-27","filed_date":"2023-09-29","scope":"insider"},{"id":8246531,"accession":"0001140361-23-043731","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001140361-23-043731","line_url":"/filing/0001140361-23-043731#line-2","is_derivative":false,"issuer_cik":"0001635088","issuer_name":"Roivant Sciences Ltd.","issuer_ticker":"ROIV","issuer_name_source":null,"issuer_url":"/issuer/0001635088","owner_cik":"0001801917","owner_name":"Venker Eric","owner_display_name":"Venker Eric","owner_url":"/insider/0001801917","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":106430.0,"shares_display":"106,430","price_per_share":12.19,"price_display":"12.19","price_state":"stated","total_value":1297381.7,"total_display":"1,297,381.70","total_whole":"1,297,382","shares_owned_after":611813.0,"shares_owned_after_display":"611,813","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-09-08","filed_date":"2023-09-12","scope":"insider"}],"collapsed":true,"next_cursor":"2023-09-08|8246531","ledger_fault":false,"count":{"value":91,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":91,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":91},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001635088","name":"Roivant Sciences Ltd.","url":"/issuer/0001635088","role":"Officer (President & Immunovant CEO)","n_filings":56,"first_seen":"2022-03-29","last_seen":"2026-07-29"},{"type":"issuer","type_label":"ISSUER","cik":"0001764013","name":"Immunovant, Inc.","url":"/issuer/0001764013","role":"Director, Officer (Chief Executive Officer)","n_filings":2,"first_seen":"2026-04-03","last_seen":"2026-07-06"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001801917","retrieved_at":"2026-08-24T16:52:27+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}